Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Three Nicotine Gum Formulations vs Nicorette Freshmint in Smokers
NCT02356913Phase 1Completed
- Sponsor
- Fertin Pharma
- Start
- Apr 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of nicotine in nicotine dependence (4 arms), sponsored by Fertin Pharma. Primary endpoints: Maximum Observed Plasma Concentration at 12 hours, Area Under the Plasma Concentration vs Time Curve until Last Measurable Concentration at 12 hours and 1 more. Started Apr 2014; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02356913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02356913.